Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation

Digestive and Liver Disease

Volumn 41, Issue 12, 2009, Pages 875-880

  Qu, J L ^a   Qu, X J ^a   Zhao, M F ^a   Teng, Y E ^a   Zhang, Y ^a   Hou, K Z ^a   Jiang, Y H ^a   Yang, X H ^a   Liu, Y P ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Akt; Cbl proteins; ERK; Exosomes

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CANCER CELL; CELL ASSAY; CELL PROLIFERATION; CENTRIFUGATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ACTIVATION; ENZYME ACTIVITY; EXOSOME; HUMAN; HUMAN CELL; ISOLATION PROCEDURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURIFICATION; STOMACH CANCER; SUCROSE DENSITY GRADIENT CENTRIFUGATION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BLOTTING, WESTERN; CELL PROLIFERATION; EXOSOMES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 70350747789     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.04.006     Document Type: Article

References (33)

1. van Niel G., Porto-Carreiro I., Simoes S., and Raposo G. Exosomes: a common pathway for a specialized function. J Biochem 140 (2006) 13-21
2. Théry C., Zitvogel L., and Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2 (2002) 569-579
3. Andre F., Schartz N.E., Movassagh M., Flament C., Pautier P., Morice P., et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360 (2002) 295-305
4. Zitvogel L., Regnault A., Lozier A., Wolfers J., Flament C., Tenza D., et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 4 (1998) 594-600
5. Heijnen H.F., Schiel A.E., Fijnheer R., Geuze H.J., and Sixma J.J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94 (1999) 3791-3799
6. Karlsson M., Lundin S., Dahlgren U., Kahu H., Pettersson I., and Telemo E. "Tolerosomes" are produced by intestinal epithelial cells. Eur J Immunol 31 (2001) 2892-2900
7. Wolfers J., Lozier A., Raposo G., Regnault A., Théry C., Masurier C., et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7 (2001) 297-303
8. Taylor D.D., and Gerçel-Taylor C. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br J Cancer 92 (2005) 305-311
9. Liu C., Yu S., Zinn K., Wang J., Zhang L., Jia Y., et al. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol 176 (2006) 1375-1385
10. Abusamra A.J., Zhong Z., Zheng X., Li M., Ichim T.E., Chin J.L., et al. Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol Dis 35 (2005) 169-173
11. Koga K., Matsumoto K., Akiyoshi T., Kubo M., Yamanaka N., Tasaki A., et al. Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res 25 (2005) 3703-3707
12. Medema R.H., and Bos J.L. The role of p21ras in receptor tyrosine kinase signaling. Crit Rev Oncog 4 (1993) 615-661
13. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10 (1998) 262-267
14. Escudier B., Dorval T., Chaput N., André F., Caby M.P., Novault S., et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J Transl Med 3 (2005) 10-22
15. Morse M.A., Garst J., Osada T., Khan S., Hobeika A., Clay T.M., et al. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med 3 (2005) 9-16
16. Dai S., Wei D., Wu Z., Zhou X., Wei X., Huang H., et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther 16 (2008) 782-790
17. Rangachari M., and Penninger J.M. Negative regulation of T cell receptor signals. Curr Opin Pharmacol 4 (2004) 415-422
18. Schmidt M.H., and Dikic I. The Cbl interactome and its functions. Nat Rev Mol Cell Biol 6 (2005) 907-918
19. Lamparski H.G., Metha-Damani A., Yao J.Y., Patel S., Hsu D.H., Ruegg C., et al. Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods 270 (2002) 211-226
20. Suthiphongchai T., Promyart P., Virochrut S., Tohtong R., and Wilairat P. Involvement of ERK1/2 in invasiveness and metastatic development of rat prostatic adenocarcinoma. Oncol Res 13 (2003) 253-259
21. Brader S., and Eccles S.A. Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis. Tumori 90 (2004) 2-8
22. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
23. Calzolari A., Raggi C., Deaglio S., Sposi N.M., Stafsnes M., Fecchi K., et al. TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway. J Cell Sci 119 (2006) 4486-4498
24. Hao S., Ye Z., Li F., Meng Q., Qureshi M., Yang J., et al. Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes. Exp Oncol 28 (2006) 126-131
25. Jung S.A., Lee H.K., Yoon J.S., Kim S.J., Kim C.Y., Song H., et al. Upregulation of TGF-beta-induced tissue transglutaminase expression by PI3K-Akt pathway activation in human subconjunctival fibroblasts. Invest Ophthalmol Vis Sci 48 (2007) 1952-1958
26. Horowitz J.C., Lee D.Y., Waghray M., Keshamouni V.G., Thomas P.E., Zhang H., et al. Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J Biol Chem 279 (2004) 1359-1367
27. Keshamouni V.G., Mattingly R.R., and Reddy K.B. Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. J Biol Chem 277 (2002) 22558-22565
28. Roos-Mattjus P., and Sistonen L. The ubiquitin-proteasome pathway. Ann Med 36 (2004) 285-295
29. Qu X., Sada K., Kyo S., Maeno K., Miah S.M., and Yamamura H. Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b. Blood 103 (2004) 1779-1786
30. Caligiuri M.A., Briesewitz R., Yu J., Wang L., Wei M., Arnoczky K.J., et al. Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia. Blood 110 (2007) 1022-1024
31. Sattler M., Salgia R., Okuda K., Uemura N., Durstin M.A., Pisick E., et al. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway. Oncogene 12 (1996) 839-846
32. Heissmeyer V., Macián F., Im S.H., Varma R., Feske S., Venuprasad K., et al. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat Immunol 5 (2004) 255-265
33. Zha Y., and Gajewski T.F. An adenoviral vector encoding dominant negative Cbl lowers the threshold for T cell activation in post-thymic T cells. Cell Immunol 247 (2007) 95-102